Find a Physician by Specialty

Breast Cancer

Medical Oncology

Oncologist

Mary Ann Fenton, MD, FACP is an oncologist at the Lifespan Cancer Institute and a clinical associate professor at The Warren Alpert Medical School of Brown University. Her specialty area is the prevention and treatment of breast cancer.

Radiation Oncology

Director of Stereotactic Radiosurgery

Jaroslaw T. Hepel, MD, serves as director of stereotactic radiosurgery at Rhode Island Hospital and as an assistant professor at The Warren Alpert Medical School of Brown University. He also serves as associate director of the Tufts-Affiliated Hospitals Residency Training Program in Radiation Oncology. He is board certified in radiation oncology by the American Board of Radiology. Hepel received his undergraduate degree at Cornell University and earned his medical degree at the University of Rochester. He completed internal medicine residency at the University of California Irvine Medical Center, and then went on to complete residency in the specialty of radiation oncology at Tufts Medical Center in Boston, MA. 

Hepel has broad experience and knowledge, and is active in caring for patients with a wide range of malignant diseases. However, he holds a particular interest and clinical expertise in the treatment of breast cancer and in stereotactic radiosurgery/radiotherapy for diseases involving the lung, brain, spine, liver and other sites. He is not only very active in the clinic but also has a keen academic interest in these areas. He has published several book chapters and multiple scientific papers, and has regularly presented his work at national meetings. Through his academic work, he strives to improve treatment outcomes for patients not only in regard to achieving higher cure rates but also to minimizing treatment side effects.

Radiation Oncologist

Kara Leonard, MD, is a radiation oncologist at Rhode Island Hospital and an assistant professor of radiation oncology at The Warren Alpert Medical School of Brown University. Leonard received her undergraduate degree in neuroscience from Columbia University in New York, NY, her master of science from Villanova University in Villanova, PA, and her medical degree from Albany Medical College in Albany, NY. She completed an internship in internal medicine at Albany Medical Center, also in Albany, NY; and completed her residency in radiation oncology at Tufts Medical Center in Boston, MA. She specializes in treating breast, gastrointestinal, and head and neck cancers. She is a member of several national honor societies, including Alpha Omega Alpha and Psi Chi.

Oncologist-in-Chief, Radiation Oncology

David Wazer, MD, is director of the Lifespan Cancer Institute of Rhode Island, The Miriam and Newport hospitals as well as radiation oncologist-in-chief at Rhode Island Hospital. He is professor and chairman of the departments of radiation oncology at both The Warren Alpert Medical School of Brown University and Tufts University School of Medicine.

Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 200 scientific articles, written several books, and is also editor-in-chief of the American Journal of Clinical Oncology. Wazer earned his medical degree (with honors) from the New York University School of Medicine, New York, NY, and also completed a research fellowship in neurochemistry at New York University. Dr. Wazer obtained his clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. His clinical research interests include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, partial breast irradiation, electronic brachytherapy and hyperthermia. He is actively involved in the development of clinical trials for cancers of the breast, skin, gastrointestinal tract and lung.

Dr. Wazer is a fellow of the American Society for Radiation Oncology and the American College of Radiation Oncology and a member of the Radiation Research Society, American Society of Clinical Oncology, the American College of Radiology, the American Radium Society, the American Association for the Advancement of Science and the American Brachytherapy Society.

Surgical Oncology

Christine Emmick, MD is a board-certified general surgeon who cares for a wide array of surgical diseases. She received her medical degree from the Albany Medical College and completed her surgical residency at The Warren Alpert Medical School of Brown University and Rhode Island Hospital. She has a special interest in the treatment of both benign and malignant breast disease and is a member of the Lifespan Cancer Institute's multidisciplinary breast clinic team at The Miriam Hospital. Dr. Emmick is an assistant clinical professor of surgery at The Warren Alpert Medical School of Brown University. She is also a member of the American College of Surgeons.

More about the Lifespan Cancer Institute »

Surgical Oncologist

Charu Taneja, MD, is an affiliated surgical oncologist in the High-Risk Breast Program at the Women's Medicine Collaborative. She is a clinical assistant professor of surgery at The Warren Alpert Medical School of Brown University. She received her medical degree from Maulana Azad Medical College, University of Delhi in New Delhi, India. Taneja completed a residency in surgery at the University of Medicine and Dentistry at New Jersey Medical School in Newark, New Jersey. She is a graduate of the surgical oncology fellowship at Boston University.

Taneja is board certified in surgery. She has published many original research articles in the field of oncology and breast surgery.

Director, Cancer Survivorship Program

Doreen Wiggins, MD, MHL, FACOG, FACS, is an affiliated physician at the Women's Medicine Collaborative. She is director of the Cancer Survivorship Medicine program and is an assistant clinical professor at The Warren Alpert Medical School of Brown University.

She received her undergraduate degree from the University of Rhode Island and her medical degree from The Warren Alpert Medical School of Brown University. She pursued further medical training at Women & Infants Hospital and completed a Society for Surgical Oncology Breast Disease fellowship, and an intensive course in cancer risk assessment at the City of Hope in Los Angeles, California. Wiggins earned a master’s degree in healthcare leadership from The Warren Alpert Medical School of Brown University.

Wiggins is a fellow of both the American College of Obstetrics and Gynecology and the American College of Surgeons. She is the founder of Center for Obstetrics & Gynecology in Providence. Her areas of expertise are breast cancer surgery, gynecologic surgery, female cancer genetics, female sexuality and cancer survivorship.


Colorectal Cancer

Medical Oncology

Medical Oncologist

Rimini A. Breakstone, MD is a medical oncologist who specializes in gastrointestinal cancers. She received her medical degree from the Robert Wood Johnson Medical School at Rutgers University and completed her residency and fellowship at The Warren Alpert Medical School of Brown University. Dr. Breakstone is board certified in hematology, oncology and internal medicine.

Prior to joining the Lifespan Cancer Institute, she was an instructor at the Hospital of the University of Pennsylvania and served on the Unit Based Clinical Leadership Committee focused on inpatient quality improvement measures. Dr. Breakstone is a member of the American Society of Clinical Oncology and the American Medical Association. Her research interests include malignancies of esophagus, stomach, biliary system, pancreas, colon and rectum.

Chief, Hematology/Oncology, Lifespan Cancer Institute

Howard P. Safran, MD is the chief of hematology/oncology at the Lifespan Cancer Institute at Rhode Island, The Miriam and Newport hospitals, and the medical director for the Brown University Oncology Group. Safran is a professor of medicine at The Warren Alpert Medical School of Brown University and a nationally recognized leader in the development of new treatments for upper GI cancers. He is a member of the U.S. National Cancer Institute's pancreatic and gastrointestinal cancer task forces.

Surgical Oncology

Colorectal Surgeon and Co-Director, Program for Pelvic Floor Disorders, Women’s Medicine Collaborative

Leslie Roth, MD, FACS, FASCRS is a colorectal surgeon and co-director of the Program for Pelvic Floor Disorders in the Center for Women’s Gastrointestinal Medicine at the Women’s Medicine Collaborative.

Dr. Roth is the Rosalyn and Joseph Sinclair Clinical Professor of Pelvic Floor Disorders and an assistant professor of surgery at The Warren Alpert Medical School of Brown University. She received her undergraduate degree from the University of Arizona and her medical degree from the Tel Aviv University Sackler School of Medicine, New York State/American Program, in Ramat Aviv, Israel and New York. 

She completed her residency at Penn State Milton S. Hershey Medical Center. She is a graduate of the colon and rectal surgery fellowship at the University of Louisville in Kentucky. Dr. Roth is board certified in both general and colorectal surgery. She is also a fellow of both the American College of Surgeons and the American Society of Colon and Rectal Surgeons. 

Dr. Roth's areas of clinical interest and expertise include colon and rectal cancer surgery, colonoscopy, laparoscopic/minimally invasive surgery, benign anorectal conditions, fecal incontinence and other pelvic floor disorders.

Colorectal Surgery

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Radiation Oncologist

Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.

Radiation Oncologist

Kara Leonard, MD, is a radiation oncologist at Rhode Island Hospital and an assistant professor of radiation oncology at The Warren Alpert Medical School of Brown University. Leonard received her undergraduate degree in neuroscience from Columbia University in New York, NY, her master of science from Villanova University in Villanova, PA, and her medical degree from Albany Medical College in Albany, NY. She completed an internship in internal medicine at Albany Medical Center, also in Albany, NY; and completed her residency in radiation oncology at Tufts Medical Center in Boston, MA. She specializes in treating breast, gastrointestinal, and head and neck cancers. She is a member of several national honor societies, including Alpha Omega Alpha and Psi Chi.


Gastrointestinal Cancer

Medical Oncology

Medical Oncologist

Rimini A. Breakstone, MD is a medical oncologist who specializes in gastrointestinal cancers. She received her medical degree from the Robert Wood Johnson Medical School at Rutgers University and completed her residency and fellowship at The Warren Alpert Medical School of Brown University. Dr. Breakstone is board certified in hematology, oncology and internal medicine.

Prior to joining the Lifespan Cancer Institute, she was an instructor at the Hospital of the University of Pennsylvania and served on the Unit Based Clinical Leadership Committee focused on inpatient quality improvement measures. Dr. Breakstone is a member of the American Society of Clinical Oncology and the American Medical Association. Her research interests include malignancies of esophagus, stomach, biliary system, pancreas, colon and rectum.

Chief, Hematology/Oncology, Lifespan Cancer Institute

Howard P. Safran, MD is the chief of hematology/oncology at the Lifespan Cancer Institute at Rhode Island, The Miriam and Newport hospitals, and the medical director for the Brown University Oncology Group. Safran is a professor of medicine at The Warren Alpert Medical School of Brown University and a nationally recognized leader in the development of new treatments for upper GI cancers. He is a member of the U.S. National Cancer Institute's pancreatic and gastrointestinal cancer task forces.

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Radiation Oncologist

Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.

Radiation Oncologist

Kara Leonard, MD, is a radiation oncologist at Rhode Island Hospital and an assistant professor of radiation oncology at The Warren Alpert Medical School of Brown University. Leonard received her undergraduate degree in neuroscience from Columbia University in New York, NY, her master of science from Villanova University in Villanova, PA, and her medical degree from Albany Medical College in Albany, NY. She completed an internship in internal medicine at Albany Medical Center, also in Albany, NY; and completed her residency in radiation oncology at Tufts Medical Center in Boston, MA. She specializes in treating breast, gastrointestinal, and head and neck cancers. She is a member of several national honor societies, including Alpha Omega Alpha and Psi Chi.

Surgical Oncology

Kevin P. Charpentier, MD, FACS is the director of the Upper GI Multidisciplinary Clinic. His expertise is as a liver, biliary, and pancreatic surgeon. He is an Associate Professor of Surgery at The Warren Alpert Medical School of Brown University. His research interests include complex liver surgery and upfront treatment of locally advanced hepatobiliary cancers to facilitate resection.

Surgeon-in-Chief, Surgery

William G. Cioffi, MD, FACS, is the surgeon-in-chief at the Miriam and Rhode Island hospitals. He is also the J. Murray Beardsley Professor and chairman of the department of surgery at The Warren Alpert Medical School of Brown University. Previously he was the chief of the burn study branch at the Institute of Surgical Research at Fort Sam Houston, Texas. He received his medical degree from the University of Vermont College of Medicine and completed his residency in general surgery at the Medical Center Hospital of Vermont.

He serves on various hospital, university and national committees dedicated to improving patient care for critically ill surgical patients. He is the past president of the American Association for the Surgery of Trauma, the International Surgical Group, the Surgical Critical Care Program Directors Society, the Society of University Surgeons and the North American Burn Society. Cioffi is currently the treasurer of the American College of Surgeons and the International Society of Burn Injuries and secretary of the American Burn Association. He is on the Executive Committee of the Board of Governors of the American College of Surgeons and serves on multiple other committees for the college and is a member of the The Halsted Society, American Surgical Association, Association for Academic Surgery, and Southern Surgical Association. Cioffi has also served on the editorial boards of such journals as Shock, Journal of Trauma, and Surgery and the American Journal of Surgery.

A board-certified general surgeon with added qualifications in surgical critical care, Cioffi’s clinical expertise and research interests are in the areas of pancreatic, oncologic, colorectal and trauma surgery. He has authored or co-authored more than 460 articles, book chapters and abstracts and continues to lecture nationally and internationally in his field.

Director of Surgical Oncology

Thomas Miner, MD, is the director of surgical oncology at Rhode Island Hospital. He is an Associate Professor of Surgery at The Warren Alpert Medical School of Brown University and an expert in gastric cancer surgery. His research interests include the use of hyperthermic intraperitoneal chemotherapy (HIPEC) for cancers with diffuse involvement of the abdominal cavity. He is one of the few surgeons in the country capable of performing this complex operation.

Director, Division Thoracic Surgery

Thomas Ng, MD, is a thoracic surgeon at Rhode Island Hospital and is an associate professor of surgery at The Warren Alpert Medical School of Brown University. Ng received his bachelor’s degree from the University of Toronto and his medical degree from Queen’s University School of Medicine in Kingston, Canada. He completed his residency in general surgery at The Warren Alpert Medical School of Brown University, a fellowship in critical care medicine at the University of Toronto and a fellowship in thoracic surgery at the University of Ottawa. Ng is active in a number of societies, including the American College of Surgeons, Canadian Association of Thoracic Surgeons, Cancer and Leukemia Group B, New England Surgical Society, Rhode Island Medical Society, Royal College of Surgeons of Canada, Society of Surgical Oncology and Society of Thoracic Surgeons.


Genetics

Oncologist

Mary Ann Fenton, MD, FACP is an oncologist at the Lifespan Cancer Institute and a clinical associate professor at The Warren Alpert Medical School of Brown University. Her specialty area is the prevention and treatment of breast cancer.

Pediatric Genetics, Geneticist

Lauren Massingham, MD is with the division of genetics at Hasbro Children’s Hospital; she is also an assistant professor of pediatrics at The Warren Alpert Medical School of Brown University. Dr. Massingham is board certified in pediatrics and clinical genetics. Her clinical interests include all aspects of pediatric genetics, with specific focus on pediatric genetics and cancer genetics. Her research interests include gene expression profiling of Turner syndrome and Down syndrome. She is a member of the American Academy of Pediatrics and Genetics Teleconference Feingold Center. 

Dr. Massingham received her medical degree from the University of Vermont College of Medicine in Burlington, VT. She completed a residency in pediatrics at University of Massachusetts Memorial Medical Center in Worcester, MA as well as a residency in medical genetics at Tufts University School of Medicine in Boston, MA. 

Mari Mori, MD, is with the division of genetics at Hasbro Children’s Hospital and also an assistant professor of pediatrics at The Warren Alpert Medical School of Brown University. Dr. Mori is board certified in clinical genetics, medical biochemical genetics, and clinical informatics. Her clinical interests include pediatric genetics and biochemical genetics. Her research interests include effects of genetic background on phenotype of Mendelian and complex genetic disorders, and improving clinical care using electronic medical records. 

Dr. Mori received her medical degree from the Nagasaki University School of Medicine in Japan. She went on to earn her MS in biomedical informatics from University of Pittsburgh School of Medicine. She completed her residency in medical genetics at the Nationwide Children’s Hospital/Ohio State University, Columbus, and fellowship in medical biochemical genetics at Duke University Medical Center in Durham.

Director of Human Genetics

Chanika Phornphutkul, MD, is the director of human genetics at Rhode Island and its Hasbro Children’s Hospital, and is an associate professor of pediatrics at The Warren Alpert Medical School of Brown University. She provides genetic risk assessment as well as counseling for patients with a family history of genetic disorders. She is board certified in pediatric endocrinology and biochemical genetics.

Phornphutkul received her medical degree from the Chiang Mai University School of Medicine in Thailand, and completed her residency at Mott Children’s Hospital in Ann Arbor, Michigan and Hasbro Children’s Hospital in Providence, Rhode Island. She completed a fellowship at Hasbro Children’s Hospital and the National Institutes of Health in Bethesda, Maryland. Her clinical and research interests focus on biochemical genetics (metabolic disorders), the application of genomic information in clinical medicine and newborn screening.


Gynecologic Oncology

Medical Oncology

Radiation Oncology

Chief of Brachytherapy Services

Yakub Puthawala, MD, is chief of brachytherapy services at Rhode Island Hospital and an associate clinical professor of radiation oncology at The Warren Alpert Medical School of Brown University. Puthawala is a board certified radiation oncologist. He received his undergraduate degree in biology from Gujarat College and his medical degree from Municipal Medical College, both in Ahmedabad, India. He completed his fellowship training in radiation oncology at the University of Massachusetts Medical Center in Worcester, MA, and his residency training in radiation oncology at University Hospital in San Juan, Puerto Rico. His areas of clinical expertise include intraoperative radiation therapy, gynecologic and head and neck oncology, high dose rate (HDR) brachytherapy and intensity modulated radiation therapy (IMRT). He is an adjunct associate clinical professor at Tufts University School of Medicine.

Surgical Oncology

Chief of OB/GYN, Rhode Island and The Miriam Hospitals

Christina A. Bandera, MD, is a gynecologic oncologist and director of the Center for Gynecologic Cancers at the Women’s Medicine Collaborative, and chief of obstetrics and gynecology at The Miriam Hospital and Rhode Island Hospital. Bandera received her undergraduate degree from Harvard University, and her medical degree from Johns Hopkins University School of Medicine. She completed her postgraduate training at Brigham & Women’s Hospital and Massachusetts General Hospital, and held fellowships at the University of Pennsylvania School of Medicine and the Mayo Clinic Hospital in Phoenix, Arizona. Bandera is board certified in obstetrics and gynecology, and gynecologic oncology. She served as director of robotic surgery at Women & Infants Hospital. She is a member of the Society of Gynecologic Oncologists and the American Association for Gynecologic Laparoscopy. Bandera’s clinical expertise includes the medical and surgical treatment of gynecologic cancers arising from the uterus, ovary, cervix, vagina and vulva, as well as the treatment of molar pregnancies and conditions resulting in abnormal pap smears. She has a special interest in cancer prevention and minimally invasive cancer surgery, including robotic surgery.


Head and Neck / Thyroid Center

Medical Oncology

Medical Oncologist

Ariel Birnbaum, MD, is a medical oncologist at Rhode Island Hospital. He received his medical degree from the Medical College of Ohio, completed his residency training at the University of Minnesota hospitals, and completed his fellowship in hematology/oncology at The Warren Alpert Medical School of Brown University. His clinical interests include combined modality treatment for lung cancer and end of life care. He is a member of the American Society of Clinical oncology and a participant in the Brown University Oncology Group.

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Radiation Oncologist

Kara Leonard, MD, is a radiation oncologist at Rhode Island Hospital and an assistant professor of radiation oncology at The Warren Alpert Medical School of Brown University. Leonard received her undergraduate degree in neuroscience from Columbia University in New York, NY, her master of science from Villanova University in Villanova, PA, and her medical degree from Albany Medical College in Albany, NY. She completed an internship in internal medicine at Albany Medical Center, also in Albany, NY; and completed her residency in radiation oncology at Tufts Medical Center in Boston, MA. She specializes in treating breast, gastrointestinal, and head and neck cancers. She is a member of several national honor societies, including Alpha Omega Alpha and Psi Chi.

Chief of Brachytherapy Services

Yakub Puthawala, MD, is chief of brachytherapy services at Rhode Island Hospital and an associate clinical professor of radiation oncology at The Warren Alpert Medical School of Brown University. Puthawala is a board certified radiation oncologist. He received his undergraduate degree in biology from Gujarat College and his medical degree from Municipal Medical College, both in Ahmedabad, India. He completed his fellowship training in radiation oncology at the University of Massachusetts Medical Center in Worcester, MA, and his residency training in radiation oncology at University Hospital in San Juan, Puerto Rico. His areas of clinical expertise include intraoperative radiation therapy, gynecologic and head and neck oncology, high dose rate (HDR) brachytherapy and intensity modulated radiation therapy (IMRT). He is an adjunct associate clinical professor at Tufts University School of Medicine.

Hematology

Hematologist / Oncologist

Gabriela Ballester, MD, is a board-certified hematologist with the Lifespan Cancer Institute. Dr. Ballester gained experience as a hematologist with New York Oncology-Hematology at Albany Medical College. She also served as a hematologist at Hospital Italiano in Buenos Aires and as an assistant professor of hematology/oncology at the Edwards Comprehensive Cancer Center at Marshall University in West Virginia. Dr. Ballester is a member of the American Society of Hematology.

Hematology Oncology

James N. Butera, MD, is a board-certified hematologist/oncologist who treats patients with blood disorders including bleeding and clotting problems, leukemia, lymphoma, and multiple myeloma. He sees patients at the Lifespan Cancer Institute at Rhode Island Hospital and the Lifespan Ambulatory Care Center in East Greenwich. He is a clinical associate professor of medicine at The Warren Alpert Medical School of Brown University.

Dr. Butera’s research findings have been published in numerous peer-reviewed journals, and he is the site principal investigator at Lifespan for several chemotherapy studies. Among other honors, Dr. Butera has received the Brown University Dean’s Excellence in Teaching Award multiple times and been named one of Rhode Island Monthly magazine’s Top Docs for several years.

Hematologist / Oncologist

Randall Ingham, MD, is a hematologist/oncologist with the Lifespan Cancer Institute and is board certified in hematology oncology and internal medicine. Dr. Ingham is an assistant professor of medicine at The Warren Alpert Medical School of Brown University. He has been a research associate for the vaccine development group at ID Biomedical Corporation/GlaxoSmithKline biologics in Massachusetts. Dr. Ingham is a member of the American Society of Clinical Oncology and the American Society of Hematology.

Director of Hematology, Lifespan Cancer Institute

Seah Lim, MD, PhD, is the director of hematology at the Lifespan Cancer Institute. He comes to Rhode Island Hospital from the Mario Lemieux Center for Blood Cancers in Pittsburgh. There, Dr. Lim led as clinical director of the adult leukemia program, as a hematology-oncologist, and a stem cell transplant physician. Dr. Lim also served as a clinical professor of hematology-oncology at the University of Pittsburgh School of Medicine. He is a fellow of the American College of Physicians.

Associate Physician-in-Chief, The Miriam Hospital; Medical Director, Lifespan Cancer Institute

Immunology

Interventional Radiology / Diagnostic Imaging

Director of Ultra Diagnostic Imaging

Damian Dupuy, MD, is the director of tumorablation at Rhode Island Hospital and a professor of diagnostic imaging at The Warren Alpert Medical School of Brown University. A pioneer in the use of image-guided ablation, Dupuy helped broaden clinical applications to successfully combat cancer involving the lung. He has been the principal investigator of two NCI funded multicenter trials involving other newer technologies, such as percutaneous microwave ablation, cryoablation and combination therapies using radio frequency with external radiation or brachy therapy. Dupuy has received national awards for research and teaching from the American College of Radiology Imaging Network, The American College of Chest Physicians and the Radiological Society of North America, where he served as the chair of the Interventional Oncology Symposium. He is also a fellow of the American College of Radiology. Dupuy has published and lectured extensively in the field of radiology and image-guided ablation, both nationally and internationally.

Director of Thoracic Radiology

Terrance T. Healey, MD, director of thoracic radiology at Rhode Island Hospital, received a medical degree from the combined Dartmouth-Brown program. He completed his residency at Rhode Island Hospital and The Warren Alpert Medical School of Brown University, and thoracic radiology fellowship at Massachusetts General Hospital and Harvard Medical School. He is an assistant professor of diagnostic imaging at The Warren Alpert Medical School of Brown University. Healey’s area of expertise involves using image-guided thermal ablation to treat lung tumors.

Medical Oncology

Hematologist / Oncologist

Gabriela Ballester, MD, is a board-certified hematologist with the Lifespan Cancer Institute. Dr. Ballester gained experience as a hematologist with New York Oncology-Hematology at Albany Medical College. She also served as a hematologist at Hospital Italiano in Buenos Aires and as an assistant professor of hematology/oncology at the Edwards Comprehensive Cancer Center at Marshall University in West Virginia. Dr. Ballester is a member of the American Society of Hematology.

Medical Oncologist

Ariel Birnbaum, MD, is a medical oncologist at Rhode Island Hospital. He received his medical degree from the Medical College of Ohio, completed his residency training at the University of Minnesota hospitals, and completed his fellowship in hematology/oncology at The Warren Alpert Medical School of Brown University. His clinical interests include combined modality treatment for lung cancer and end of life care. He is a member of the American Society of Clinical oncology and a participant in the Brown University Oncology Group.

Medical Oncologist

Rimini A. Breakstone, MD is a medical oncologist who specializes in gastrointestinal cancers. She received her medical degree from the Robert Wood Johnson Medical School at Rutgers University and completed her residency and fellowship at The Warren Alpert Medical School of Brown University. Dr. Breakstone is board certified in hematology, oncology and internal medicine.

Prior to joining the Lifespan Cancer Institute, she was an instructor at the Hospital of the University of Pennsylvania and served on the Unit Based Clinical Leadership Committee focused on inpatient quality improvement measures. Dr. Breakstone is a member of the American Society of Clinical Oncology and the American Medical Association. Her research interests include malignancies of esophagus, stomach, biliary system, pancreas, colon and rectum.

Hematology Oncology

James N. Butera, MD, is a board-certified hematologist/oncologist who treats patients with blood disorders including bleeding and clotting problems, leukemia, lymphoma, and multiple myeloma. He sees patients at the Lifespan Cancer Institute at Rhode Island Hospital and the Lifespan Ambulatory Care Center in East Greenwich. He is a clinical associate professor of medicine at The Warren Alpert Medical School of Brown University.

Dr. Butera’s research findings have been published in numerous peer-reviewed journals, and he is the site principal investigator at Lifespan for several chemotherapy studies. Among other honors, Dr. Butera has received the Brown University Dean’s Excellence in Teaching Award multiple times and been named one of Rhode Island Monthly magazine’s Top Docs for several years.

Neuro-Oncology Medical Lead, Lifespan Cancer Institute

Heinrich Elinzano, MD is an adult neurologist, with subspecialty training in neuro-oncology and spinal cord injury medicine, and is also an assistant professor of neurology at The Warren Alpert Medical School of Brown University. He is experienced in the management of tumors of the central nervous system and has a particular interest in conducting clinical trials for the treatment of primary brain tumors and the neurological complications of systemic cancer.

Elinzano completed his neurology residency at St. Vincent Hospital and Medical Center of New York, his spinal cord injury medicine fellowship training at Barnes-Jewish Hospital at Washington University Medical Center in St. Louis, Missouri, and his neuro-oncology fellowship training at The Johns Hopkins University School of Medicine in Baltimore and The Neuro-Oncology Branch of the U.S. National Institutes of Health's National Cancer Institute and National Institute of Neurologic Diseases and Stroke. Prior to his current position at Rhode Island Hospital, he was an adult neuro-oncologist at the Cleveland Clinic Brain Tumor and Neuro-Oncology Center.

Oncologist

Mary Ann Fenton, MD, FACP is an oncologist at the Lifespan Cancer Institute and a clinical associate professor at The Warren Alpert Medical School of Brown University. Her specialty area is the prevention and treatment of breast cancer.

Hematologist / Oncologist

Randall Ingham, MD, is a hematologist/oncologist with the Lifespan Cancer Institute and is board certified in hematology oncology and internal medicine. Dr. Ingham is an assistant professor of medicine at The Warren Alpert Medical School of Brown University. He has been a research associate for the vaccine development group at ID Biomedical Corporation/GlaxoSmithKline biologics in Massachusetts. Dr. Ingham is a member of the American Society of Clinical Oncology and the American Society of Hematology.

Director, Lifespan Cancer Institute Thoracic Multidisciplinary Clinic

Humera Khurshid, MD, is the director of the Lifespan Cancer Institute’s Thoracic Multidisciplinary Clinic, where she sees patients and collaborates with a team of specialists to coordinate patient care for newly diagnosed lung cancer patients. She is a medical oncologist with a special interest in geriatric oncology and the care of older lung cancer patients. She is also an assistant professor at The Warren Alpert Medical School of Brown University.

Director of Hematology, Lifespan Cancer Institute

Seah Lim, MD, PhD, is the director of hematology at the Lifespan Cancer Institute. He comes to Rhode Island Hospital from the Mario Lemieux Center for Blood Cancers in Pittsburgh. There, Dr. Lim led as clinical director of the adult leukemia program, as a hematology-oncologist, and a stem cell transplant physician. Dr. Lim also served as a clinical professor of hematology-oncology at the University of Pittsburgh School of Medicine. He is a fellow of the American College of Physicians.

Alexander Mohler, MD, MS is a neurologist and neuro-oncologist with the Lifespan Cancer Institute at Rhode Island, The Miriam, and Newport hospitals, and an assistant professor of neurology at The Warren Alpert Medical School of Brown University.

Dr. Mohler received his medical degree at the University of South Florida Morsani College of Medicine in Tampa, and a master of science in physiology and biophysics from Georgetown University in Washington, DC. He completed his neurology residency and a neuro-oncology fellowship at University of Colorado, Anschutz Medical Campus in Denver. He is a member of the American Academy of Neurology and the Society for Neuro-Oncology

Chief, Hematology/Oncology, Lifespan Cancer Institute

Howard P. Safran, MD is the chief of hematology/oncology at the Lifespan Cancer Institute at Rhode Island, The Miriam and Newport hospitals, and the medical director for the Brown University Oncology Group. Safran is a professor of medicine at The Warren Alpert Medical School of Brown University and a nationally recognized leader in the development of new treatments for upper GI cancers. He is a member of the U.S. National Cancer Institute's pancreatic and gastrointestinal cancer task forces.

Associate Physician-in-Chief, The Miriam Hospital; Medical Director, Lifespan Cancer Institute

Angela Taber, MD, is a palliative care specialist and medical oncologist at the Lifespan Cancer Institute at Rhode Island, The Miriam, and Newport hospitals. She has a special interest in issues involving patient quality of life, improving doctor-patient communication, and palliative care for patients with lung cancer. She is board certified in palliative care, and is an active participant in the Brown University Oncology Group, where she is involved in the development of clinical research protocols.

Taber earned her medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts, and completed her residency and hematology-oncology fellowship at The Warren Alpert Medical School of Brown University in Providence, Rhode Island. She is a member of theAmerican Society of Clinical Oncology and the American Academy of Hospice and Palliative Medicine, and has been honored nationally for outstanding compassion and cancer care by the American Cancer Society. She is also the American Cancer Society’s designee to the Palliative Care and Quality of Life Interdisciplinary Advisory Council for the state of Rhode Island.

Neuro-Oncology

Neurology/Medical Oncology

Neuro-Oncology Medical Lead, Lifespan Cancer Institute

Heinrich Elinzano, MD is an adult neurologist, with subspecialty training in neuro-oncology and spinal cord injury medicine, and is also an assistant professor of neurology at The Warren Alpert Medical School of Brown University. He is experienced in the management of tumors of the central nervous system and has a particular interest in conducting clinical trials for the treatment of primary brain tumors and the neurological complications of systemic cancer.

Elinzano completed his neurology residency at St. Vincent Hospital and Medical Center of New York, his spinal cord injury medicine fellowship training at Barnes-Jewish Hospital at Washington University Medical Center in St. Louis, Missouri, and his neuro-oncology fellowship training at The Johns Hopkins University School of Medicine in Baltimore and The Neuro-Oncology Branch of the U.S. National Institutes of Health's National Cancer Institute and National Institute of Neurologic Diseases and Stroke. Prior to his current position at Rhode Island Hospital, he was an adult neuro-oncologist at the Cleveland Clinic Brain Tumor and Neuro-Oncology Center.

Alexander Mohler, MD, MS is a neurologist and neuro-oncologist with the Lifespan Cancer Institute at Rhode Island, The Miriam, and Newport hospitals, and an assistant professor of neurology at The Warren Alpert Medical School of Brown University.

Dr. Mohler received his medical degree at the University of South Florida Morsani College of Medicine in Tampa, and a master of science in physiology and biophysics from Georgetown University in Washington, DC. He completed his neurology residency and a neuro-oncology fellowship at University of Colorado, Anschutz Medical Campus in Denver. He is a member of the American Academy of Neurology and the Society for Neuro-Oncology

Radiation Oncology

Radiation Oncologist

Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.

Palliative Care

Angela Taber, MD, is a palliative care specialist and medical oncologist at the Lifespan Cancer Institute at Rhode Island, The Miriam, and Newport hospitals. She has a special interest in issues involving patient quality of life, improving doctor-patient communication, and palliative care for patients with lung cancer. She is board certified in palliative care, and is an active participant in the Brown University Oncology Group, where she is involved in the development of clinical research protocols.

Taber earned her medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts, and completed her residency and hematology-oncology fellowship at The Warren Alpert Medical School of Brown University in Providence, Rhode Island. She is a member of theAmerican Society of Clinical Oncology and the American Academy of Hospice and Palliative Medicine, and has been honored nationally for outstanding compassion and cancer care by the American Cancer Society. She is also the American Cancer Society’s designee to the Palliative Care and Quality of Life Interdisciplinary Advisory Council for the state of Rhode Island.

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Director of Stereotactic Radiosurgery

Jaroslaw T. Hepel, MD, serves as director of stereotactic radiosurgery at Rhode Island Hospital and as an assistant professor at The Warren Alpert Medical School of Brown University. He also serves as associate director of the Tufts-Affiliated Hospitals Residency Training Program in Radiation Oncology. He is board certified in radiation oncology by the American Board of Radiology. Hepel received his undergraduate degree at Cornell University and earned his medical degree at the University of Rochester. He completed internal medicine residency at the University of California Irvine Medical Center, and then went on to complete residency in the specialty of radiation oncology at Tufts Medical Center in Boston, MA. 

Hepel has broad experience and knowledge, and is active in caring for patients with a wide range of malignant diseases. However, he holds a particular interest and clinical expertise in the treatment of breast cancer and in stereotactic radiosurgery/radiotherapy for diseases involving the lung, brain, spine, liver and other sites. He is not only very active in the clinic but also has a keen academic interest in these areas. He has published several book chapters and multiple scientific papers, and has regularly presented his work at national meetings. Through his academic work, he strives to improve treatment outcomes for patients not only in regard to achieving higher cure rates but also to minimizing treatment side effects.

Radiation Oncologist

Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.

Radiation Oncologist

Kara Leonard, MD, is a radiation oncologist at Rhode Island Hospital and an assistant professor of radiation oncology at The Warren Alpert Medical School of Brown University. Leonard received her undergraduate degree in neuroscience from Columbia University in New York, NY, her master of science from Villanova University in Villanova, PA, and her medical degree from Albany Medical College in Albany, NY. She completed an internship in internal medicine at Albany Medical Center, also in Albany, NY; and completed her residency in radiation oncology at Tufts Medical Center in Boston, MA. She specializes in treating breast, gastrointestinal, and head and neck cancers. She is a member of several national honor societies, including Alpha Omega Alpha and Psi Chi.

Chief of Brachytherapy Services

Yakub Puthawala, MD, is chief of brachytherapy services at Rhode Island Hospital and an associate clinical professor of radiation oncology at The Warren Alpert Medical School of Brown University. Puthawala is a board certified radiation oncologist. He received his undergraduate degree in biology from Gujarat College and his medical degree from Municipal Medical College, both in Ahmedabad, India. He completed his fellowship training in radiation oncology at the University of Massachusetts Medical Center in Worcester, MA, and his residency training in radiation oncology at University Hospital in San Juan, Puerto Rico. His areas of clinical expertise include intraoperative radiation therapy, gynecologic and head and neck oncology, high dose rate (HDR) brachytherapy and intensity modulated radiation therapy (IMRT). He is an adjunct associate clinical professor at Tufts University School of Medicine.

Oncologist-in-Chief, Radiation Oncology

David Wazer, MD, is director of the Lifespan Cancer Institute of Rhode Island, The Miriam and Newport hospitals as well as radiation oncologist-in-chief at Rhode Island Hospital. He is professor and chairman of the departments of radiation oncology at both The Warren Alpert Medical School of Brown University and Tufts University School of Medicine.

Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 200 scientific articles, written several books, and is also editor-in-chief of the American Journal of Clinical Oncology. Wazer earned his medical degree (with honors) from the New York University School of Medicine, New York, NY, and also completed a research fellowship in neurochemistry at New York University. Dr. Wazer obtained his clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. His clinical research interests include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, partial breast irradiation, electronic brachytherapy and hyperthermia. He is actively involved in the development of clinical trials for cancers of the breast, skin, gastrointestinal tract and lung.

Dr. Wazer is a fellow of the American Society for Radiation Oncology and the American College of Radiation Oncology and a member of the Radiation Research Society, American Society of Clinical Oncology, the American College of Radiology, the American Radium Society, the American Association for the Advancement of Science and the American Brachytherapy Society.

Skin Cancer/Melanoma

Dermatology

Medical Oncology

Radiation Oncology

Chief of Brachytherapy Services

Yakub Puthawala, MD, is chief of brachytherapy services at Rhode Island Hospital and an associate clinical professor of radiation oncology at The Warren Alpert Medical School of Brown University. Puthawala is a board certified radiation oncologist. He received his undergraduate degree in biology from Gujarat College and his medical degree from Municipal Medical College, both in Ahmedabad, India. He completed his fellowship training in radiation oncology at the University of Massachusetts Medical Center in Worcester, MA, and his residency training in radiation oncology at University Hospital in San Juan, Puerto Rico. His areas of clinical expertise include intraoperative radiation therapy, gynecologic and head and neck oncology, high dose rate (HDR) brachytherapy and intensity modulated radiation therapy (IMRT). He is an adjunct associate clinical professor at Tufts University School of Medicine.

Oncologist-in-Chief, Radiation Oncology

David Wazer, MD, is director of the Lifespan Cancer Institute of Rhode Island, The Miriam and Newport hospitals as well as radiation oncologist-in-chief at Rhode Island Hospital. He is professor and chairman of the departments of radiation oncology at both The Warren Alpert Medical School of Brown University and Tufts University School of Medicine.

Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 200 scientific articles, written several books, and is also editor-in-chief of the American Journal of Clinical Oncology. Wazer earned his medical degree (with honors) from the New York University School of Medicine, New York, NY, and also completed a research fellowship in neurochemistry at New York University. Dr. Wazer obtained his clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. His clinical research interests include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, partial breast irradiation, electronic brachytherapy and hyperthermia. He is actively involved in the development of clinical trials for cancers of the breast, skin, gastrointestinal tract and lung.

Dr. Wazer is a fellow of the American Society for Radiation Oncology and the American College of Radiation Oncology and a member of the Radiation Research Society, American Society of Clinical Oncology, the American College of Radiology, the American Radium Society, the American Association for the Advancement of Science and the American Brachytherapy Society.

Surgical Oncology

Director of Surgical Oncology

Thomas Miner, MD, is the director of surgical oncology at Rhode Island Hospital. He is an Associate Professor of Surgery at The Warren Alpert Medical School of Brown University and an expert in gastric cancer surgery. His research interests include the use of hyperthermic intraperitoneal chemotherapy (HIPEC) for cancers with diffuse involvement of the abdominal cavity. He is one of the few surgeons in the country capable of performing this complex operation.

Surgical Oncology

Chief of OB/GYN, Rhode Island and The Miriam Hospitals

Christina A. Bandera, MD, is a gynecologic oncologist and director of the Center for Gynecologic Cancers at the Women’s Medicine Collaborative, and chief of obstetrics and gynecology at The Miriam Hospital and Rhode Island Hospital. Bandera received her undergraduate degree from Harvard University, and her medical degree from Johns Hopkins University School of Medicine. She completed her postgraduate training at Brigham & Women’s Hospital and Massachusetts General Hospital, and held fellowships at the University of Pennsylvania School of Medicine and the Mayo Clinic Hospital in Phoenix, Arizona. Bandera is board certified in obstetrics and gynecology, and gynecologic oncology. She served as director of robotic surgery at Women & Infants Hospital. She is a member of the Society of Gynecologic Oncologists and the American Association for Gynecologic Laparoscopy. Bandera’s clinical expertise includes the medical and surgical treatment of gynecologic cancers arising from the uterus, ovary, cervix, vagina and vulva, as well as the treatment of molar pregnancies and conditions resulting in abnormal pap smears. She has a special interest in cancer prevention and minimally invasive cancer surgery, including robotic surgery.

Kevin P. Charpentier, MD, FACS is the director of the Upper GI Multidisciplinary Clinic. His expertise is as a liver, biliary, and pancreatic surgeon. He is an Associate Professor of Surgery at The Warren Alpert Medical School of Brown University. His research interests include complex liver surgery and upfront treatment of locally advanced hepatobiliary cancers to facilitate resection.

Surgeon-in-Chief, Surgery

William G. Cioffi, MD, FACS, is the surgeon-in-chief at the Miriam and Rhode Island hospitals. He is also the J. Murray Beardsley Professor and chairman of the department of surgery at The Warren Alpert Medical School of Brown University. Previously he was the chief of the burn study branch at the Institute of Surgical Research at Fort Sam Houston, Texas. He received his medical degree from the University of Vermont College of Medicine and completed his residency in general surgery at the Medical Center Hospital of Vermont.

He serves on various hospital, university and national committees dedicated to improving patient care for critically ill surgical patients. He is the past president of the American Association for the Surgery of Trauma, the International Surgical Group, the Surgical Critical Care Program Directors Society, the Society of University Surgeons and the North American Burn Society. Cioffi is currently the treasurer of the American College of Surgeons and the International Society of Burn Injuries and secretary of the American Burn Association. He is on the Executive Committee of the Board of Governors of the American College of Surgeons and serves on multiple other committees for the college and is a member of the The Halsted Society, American Surgical Association, Association for Academic Surgery, and Southern Surgical Association. Cioffi has also served on the editorial boards of such journals as Shock, Journal of Trauma, and Surgery and the American Journal of Surgery.

A board-certified general surgeon with added qualifications in surgical critical care, Cioffi’s clinical expertise and research interests are in the areas of pancreatic, oncologic, colorectal and trauma surgery. He has authored or co-authored more than 460 articles, book chapters and abstracts and continues to lecture nationally and internationally in his field.

Christine Emmick, MD is a board-certified general surgeon who cares for a wide array of surgical diseases. She received her medical degree from the Albany Medical College and completed her surgical residency at The Warren Alpert Medical School of Brown University and Rhode Island Hospital. She has a special interest in the treatment of both benign and malignant breast disease and is a member of the Lifespan Cancer Institute's multidisciplinary breast clinic team at The Miriam Hospital. Dr. Emmick is an assistant clinical professor of surgery at The Warren Alpert Medical School of Brown University. She is also a member of the American College of Surgeons.

More about the Lifespan Cancer Institute »

Boris Gershman MD is an assistant professor of surgery (clinical) (urology) at The Warren Alpert Medical School of Brown University.  Dr. Gershman's clinical interests focus on urologic oncology, including the management of prostate, kidney, bladder, and testicular cancer.  He has a broad research interest in comparative effectiveness and health services research, with a particular focus on risk-stratification for urologic malignancies and quality measurement.

Gershman graduated magna cum laude from Brown University and received his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed residency training at the Massachusetts General Hospital followed by a Society of Urologic Oncology (SUO) fellowship at Mayo Clinic.  He has received numerous institutional and organizational honors and awards including the Maria L. Caleel Memorial Award for Academic Excellence, the Dr. I. S. Ravdin Memorial Prize in Surgery, the Dr. Spencer Morris Prize, and induction into the Alpha Omega Alpha medical honor society. He serves as a reviewer for multiple journals, and has been recognized as Reviewer of the Year by European Urology.

Director, Minimally Invasive Urology Institute

Dragan Golijanin, MD, is a director of the Minimally Invasive Urology Institute and director of Genitourinary Oncology at The Miriam Hospital. He also serves as an associate professor of surgery (urology) at The Warren Alpert Medical School of Brown University. His areas of expertise include prostate cancer, kidney cancer, bladder cancer and testicular cancer. Golijanin is board certified in urology.

Golijanin earned his medical degree at the University of Belgrade. He completed residencies at the University of Rochester School of Medicine, University Clinical Center in Belgrade and Hadassah Medical Center. He completed fellowships in urologic oncology at Memorial Sloan-Kettering Cancer Center and Cornell University and Hadassah Medical Center, and was the first to publish on near-infrared real-time imaging in open laparoscopic and robotic surgery.

 

Director of Surgical Oncology

Thomas Miner, MD, is the director of surgical oncology at Rhode Island Hospital. He is an Associate Professor of Surgery at The Warren Alpert Medical School of Brown University and an expert in gastric cancer surgery. His research interests include the use of hyperthermic intraperitoneal chemotherapy (HIPEC) for cancers with diffuse involvement of the abdominal cavity. He is one of the few surgeons in the country capable of performing this complex operation.

Director, Division Thoracic Surgery

Thomas Ng, MD, is a thoracic surgeon at Rhode Island Hospital and is an associate professor of surgery at The Warren Alpert Medical School of Brown University. Ng received his bachelor’s degree from the University of Toronto and his medical degree from Queen’s University School of Medicine in Kingston, Canada. He completed his residency in general surgery at The Warren Alpert Medical School of Brown University, a fellowship in critical care medicine at the University of Toronto and a fellowship in thoracic surgery at the University of Ottawa. Ng is active in a number of societies, including the American College of Surgeons, Canadian Association of Thoracic Surgeons, Cancer and Leukemia Group B, New England Surgical Society, Rhode Island Medical Society, Royal College of Surgeons of Canada, Society of Surgical Oncology and Society of Thoracic Surgeons.

Director, Minimally Invasive Urology Institute

Joseph F.Renzulli II, MD, is a director of the Minimally Invasive Urology Institute and director of the Prostate Surgery Program at The Miriam Hospital. He is also an associate professor of surgery (urology) at The Warren Alpert Medical School of Brown University. His areas of expertise include prostate cancer, kidney cancer, bladder cancer and testicular cancer. Renzulli is board certified in urology and is a fellow of the American College of Surgeons.

Renzulli received his medical degree from Boston University and later completed his residency at Yale University School of Medicine. In 2006, Renzulli was part of a team at The Miriam Hospital that performed the first robotic prostatectomy in the state of Rhode Island.

  

Colorectal Surgeon and Co-Director, Program for Pelvic Floor Disorders, Women’s Medicine Collaborative

Leslie Roth, MD, FACS, FASCRS is a colorectal surgeon and co-director of the Program for Pelvic Floor Disorders in the Center for Women’s Gastrointestinal Medicine at the Women’s Medicine Collaborative.

Dr. Roth is the Rosalyn and Joseph Sinclair Clinical Professor of Pelvic Floor Disorders and an assistant professor of surgery at The Warren Alpert Medical School of Brown University. She received her undergraduate degree from the University of Arizona and her medical degree from the Tel Aviv University Sackler School of Medicine, New York State/American Program, in Ramat Aviv, Israel and New York. 

She completed her residency at Penn State Milton S. Hershey Medical Center. She is a graduate of the colon and rectal surgery fellowship at the University of Louisville in Kentucky. Dr. Roth is board certified in both general and colorectal surgery. She is also a fellow of both the American College of Surgeons and the American Society of Colon and Rectal Surgeons. 

Dr. Roth's areas of clinical interest and expertise include colon and rectal cancer surgery, colonoscopy, laparoscopic/minimally invasive surgery, benign anorectal conditions, fecal incontinence and other pelvic floor disorders.

Colorectal Surgery
Surgical Oncologist

Charu Taneja, MD, is an affiliated surgical oncologist in the High-Risk Breast Program at the Women's Medicine Collaborative. She is a clinical assistant professor of surgery at The Warren Alpert Medical School of Brown University. She received her medical degree from Maulana Azad Medical College, University of Delhi in New Delhi, India. Taneja completed a residency in surgery at the University of Medicine and Dentistry at New Jersey Medical School in Newark, New Jersey. She is a graduate of the surgical oncology fellowship at Boston University.

Taneja is board certified in surgery. She has published many original research articles in the field of oncology and breast surgery.

Director, Cancer Survivorship Program

Doreen Wiggins, MD, MHL, FACOG, FACS, is an affiliated physician at the Women's Medicine Collaborative. She is director of the Cancer Survivorship Medicine program and is an assistant clinical professor at The Warren Alpert Medical School of Brown University.

She received her undergraduate degree from the University of Rhode Island and her medical degree from The Warren Alpert Medical School of Brown University. She pursued further medical training at Women & Infants Hospital and completed a Society for Surgical Oncology Breast Disease fellowship, and an intensive course in cancer risk assessment at the City of Hope in Los Angeles, California. Wiggins earned a master’s degree in healthcare leadership from The Warren Alpert Medical School of Brown University.

Wiggins is a fellow of both the American College of Obstetrics and Gynecology and the American College of Surgeons. She is the founder of Center for Obstetrics & Gynecology in Providence. Her areas of expertise are breast cancer surgery, gynecologic surgery, female cancer genetics, female sexuality and cancer survivorship.

Thoracic Cancer

Medical Oncology

Medical Oncologist

Ariel Birnbaum, MD, is a medical oncologist at Rhode Island Hospital. He received his medical degree from the Medical College of Ohio, completed his residency training at the University of Minnesota hospitals, and completed his fellowship in hematology/oncology at The Warren Alpert Medical School of Brown University. His clinical interests include combined modality treatment for lung cancer and end of life care. He is a member of the American Society of Clinical oncology and a participant in the Brown University Oncology Group.

Director, Lifespan Cancer Institute Thoracic Multidisciplinary Clinic

Humera Khurshid, MD, is the director of the Lifespan Cancer Institute’s Thoracic Multidisciplinary Clinic, where she sees patients and collaborates with a team of specialists to coordinate patient care for newly diagnosed lung cancer patients. She is a medical oncologist with a special interest in geriatric oncology and the care of older lung cancer patients. She is also an assistant professor at The Warren Alpert Medical School of Brown University.

Angela Taber, MD, is a palliative care specialist and medical oncologist at the Lifespan Cancer Institute at Rhode Island, The Miriam, and Newport hospitals. She has a special interest in issues involving patient quality of life, improving doctor-patient communication, and palliative care for patients with lung cancer. She is board certified in palliative care, and is an active participant in the Brown University Oncology Group, where she is involved in the development of clinical research protocols.

Taber earned her medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts, and completed her residency and hematology-oncology fellowship at The Warren Alpert Medical School of Brown University in Providence, Rhode Island. She is a member of theAmerican Society of Clinical Oncology and the American Academy of Hospice and Palliative Medicine, and has been honored nationally for outstanding compassion and cancer care by the American Cancer Society. She is also the American Cancer Society’s designee to the Palliative Care and Quality of Life Interdisciplinary Advisory Council for the state of Rhode Island.

Pulmonology

Kevin Dushay, MD, specializes in pulmonary and critical care medicine in the Interventional Pulmonary Program at Rhode Island Hospital. He graduated from the College of Physicians and Surgeons of Columbia University, and then completed his residency at Beth Israel Hospital and his pulmonary and critical care fellowship at the Deaconess Hospital, both Harvard Medical School university teaching hospitals. Dushay has special interests in interventional pulmonology, lung cancer, and interstitial lung diseases. He is board certified in internal medicine, pulmonary diseases, and critical care medicine, and is an associate medical director for critical care of the New England Organ Bank. He is a member of the American Thoracic Society, the Rhode Island Thoracic Society, the American Society of Respiratory Care, and is a fellow of the American College of Chest Physicians. He is a member of the Alpha Omega Alpha Honor Medical Society.

Douglas Martin, MD, specializes in pulmonary diseases and critical care medicine in the Interventional Pulmonary Program at Rhode Island Hospital. He graduated from The University of Rochester School of Medicine and Dentistry and then completed his residency and pulmonary and critical care fellowship at The Warren Alpert Medical School of Brown University. Martin has a special interest in lung cancer, bronchoscopy and interventional pulmonary procedures. He is board certified in internal medicine, pulmonary diseases, and criticalcare medicine. He is a member of The American Thoracic Society and The American College of Chest Physicians.

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Director of Stereotactic Radiosurgery

Jaroslaw T. Hepel, MD, serves as director of stereotactic radiosurgery at Rhode Island Hospital and as an assistant professor at The Warren Alpert Medical School of Brown University. He also serves as associate director of the Tufts-Affiliated Hospitals Residency Training Program in Radiation Oncology. He is board certified in radiation oncology by the American Board of Radiology. Hepel received his undergraduate degree at Cornell University and earned his medical degree at the University of Rochester. He completed internal medicine residency at the University of California Irvine Medical Center, and then went on to complete residency in the specialty of radiation oncology at Tufts Medical Center in Boston, MA. 

Hepel has broad experience and knowledge, and is active in caring for patients with a wide range of malignant diseases. However, he holds a particular interest and clinical expertise in the treatment of breast cancer and in stereotactic radiosurgery/radiotherapy for diseases involving the lung, brain, spine, liver and other sites. He is not only very active in the clinic but also has a keen academic interest in these areas. He has published several book chapters and multiple scientific papers, and has regularly presented his work at national meetings. Through his academic work, he strives to improve treatment outcomes for patients not only in regard to achieving higher cure rates but also to minimizing treatment side effects.

Surgical Oncology

Director, Division Thoracic Surgery

Thomas Ng, MD, is a thoracic surgeon at Rhode Island Hospital and is an associate professor of surgery at The Warren Alpert Medical School of Brown University. Ng received his bachelor’s degree from the University of Toronto and his medical degree from Queen’s University School of Medicine in Kingston, Canada. He completed his residency in general surgery at The Warren Alpert Medical School of Brown University, a fellowship in critical care medicine at the University of Toronto and a fellowship in thoracic surgery at the University of Ottawa. Ng is active in a number of societies, including the American College of Surgeons, Canadian Association of Thoracic Surgeons, Cancer and Leukemia Group B, New England Surgical Society, Rhode Island Medical Society, Royal College of Surgeons of Canada, Society of Surgical Oncology and Society of Thoracic Surgeons.

Urology

Medical Oncology

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Surgical Oncology

Boris Gershman MD is an assistant professor of surgery (clinical) (urology) at The Warren Alpert Medical School of Brown University.  Dr. Gershman's clinical interests focus on urologic oncology, including the management of prostate, kidney, bladder, and testicular cancer.  He has a broad research interest in comparative effectiveness and health services research, with a particular focus on risk-stratification for urologic malignancies and quality measurement.

Gershman graduated magna cum laude from Brown University and received his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed residency training at the Massachusetts General Hospital followed by a Society of Urologic Oncology (SUO) fellowship at Mayo Clinic.  He has received numerous institutional and organizational honors and awards including the Maria L. Caleel Memorial Award for Academic Excellence, the Dr. I. S. Ravdin Memorial Prize in Surgery, the Dr. Spencer Morris Prize, and induction into the Alpha Omega Alpha medical honor society. He serves as a reviewer for multiple journals, and has been recognized as Reviewer of the Year by European Urology.

Director, Minimally Invasive Urology Institute

Dragan Golijanin, MD, is a director of the Minimally Invasive Urology Institute and director of Genitourinary Oncology at The Miriam Hospital. He also serves as an associate professor of surgery (urology) at The Warren Alpert Medical School of Brown University. His areas of expertise include prostate cancer, kidney cancer, bladder cancer and testicular cancer. Golijanin is board certified in urology.

Golijanin earned his medical degree at the University of Belgrade. He completed residencies at the University of Rochester School of Medicine, University Clinical Center in Belgrade and Hadassah Medical Center. He completed fellowships in urologic oncology at Memorial Sloan-Kettering Cancer Center and Cornell University and Hadassah Medical Center, and was the first to publish on near-infrared real-time imaging in open laparoscopic and robotic surgery.

 

Director, Minimally Invasive Urology Institute

Joseph F.Renzulli II, MD, is a director of the Minimally Invasive Urology Institute and director of the Prostate Surgery Program at The Miriam Hospital. He is also an associate professor of surgery (urology) at The Warren Alpert Medical School of Brown University. His areas of expertise include prostate cancer, kidney cancer, bladder cancer and testicular cancer. Renzulli is board certified in urology and is a fellow of the American College of Surgeons.

Renzulli received his medical degree from Boston University and later completed his residency at Yale University School of Medicine. In 2006, Renzulli was part of a team at The Miriam Hospital that performed the first robotic prostatectomy in the state of Rhode Island.